Literature DB >> 15588246

Thyroid follicular adenomas may display features of follicular carcinoma and follicular variant of papillary carcinoma.

Vasily V Vasko1, Jean Gaudart, Claude Allasia, Victoria Savchenko, Julie Di Cristofaro, Motoyasu Saji, Matthew D Ringel, Catherine De Micco.   

Abstract

Thyroid follicular adenomas (FA) are encapsulated tumors lacking vascular, capsular or lymphatic invasion and the typical nuclear features of papillary carcinoma (PC). However, some FA demonstrate nuclear atypia reminiscent of either follicular carcinomas (FC) or follicular variant of papillary carcinomas (FVPC), suggesting they may represent precursors of malignant transformation. We hypothesized that an objective evaluation of nuclear chromatin patterns could be used to define atypical follicular tumors (AFT) that are likely to be premalignant. To test this hypothesis, we used a computer-aided image analysis system to define the chromatin pattern of nuclei from thyroid tumors. To validate the system, we analyzed 3000 nuclei from 10 FA, 10 FC, and 10 FVPC samples and accurately distinguished between these classes of tumors. Then, we analyzed nine AFT and, in parallel, we analyzed the tumors for activating mutations of N2-RAS and over-expression of RET. The predominant chromatin pattern of AFT was of FA type in two cases, FC type in two cases, and PC type in three cases. One case contained similar numbers of FC and PC nuclei and one was comprised of a mixture of the three nuclear types. Neither RAS mutation nor RET overexpression were detected in FA. N2-RAS mutations were found in 33% of AFT, 20% of FC and 20% of FVPC without correlation with chromatin pattern. Over-expression of RET was detected in 45% of AFT, 20% of FC and 50% of FVPC and was correlated with PC nuclei. These results show that AFT are a heterogeneous group of tumors, containing genuine benign tumors and tumors that share morphological and molecular features with follicular and papillary carcinomas that might be precursors of both types of thyroid carcinomas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15588246     DOI: 10.1530/eje.0.1510779

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  19 in total

1.  An optimal transportation approach for nuclear structure-based pathology.

Authors:  Wei Wang; John A Ozolek; Dejan Slepčev; Ann B Lee; Cheng Chen; Gustavo K Rohde
Journal:  IEEE Trans Med Imaging       Date:  2010-10-25       Impact factor: 10.048

Review 2.  Molecular analysis of thyroid tumors.

Authors:  Feriyl Bhaijee; Yuri E Nikiforov
Journal:  Endocr Pathol       Date:  2011-09       Impact factor: 3.943

Review 3.  Diagnostic biomarkers of differentiated thyroid cancer.

Authors:  Tada Kunavisarut
Journal:  Endocrine       Date:  2013-05-04       Impact factor: 3.633

Review 4.  Values of molecular markers in the differential diagnosis of thyroid abnormalities.

Authors:  T M P B Tennakoon; M Rushdhi; A D C U Ranasinghe; R S Dassanayake
Journal:  J Cancer Res Clin Oncol       Date:  2016-12-22       Impact factor: 4.553

5.  Telomere length is related to alternative splice patterns of telomerase in thyroid tumors.

Authors:  Yongchun Wang; Alan K Meeker; Jeanne Kowalski; Hua-Ling Tsai; Helina Somervell; Christopher Heaphy; Lauren E Sangenario; Nijaguna Prasad; William H Westra; Martha A Zeiger; Christopher B Umbricht
Journal:  Am J Pathol       Date:  2011-07-16       Impact factor: 4.307

6.  Encapsulated Follicular Variant of Papillary Thyroid Carcinoma Arising in a Follicular Adenoma: a Diagnostic Dilemma.

Authors:  Kanika Singh; Mukta Pujani; Varsha Chauhan; Charu Agarwal; Shruti Dhingra
Journal:  Indian J Surg Oncol       Date:  2018-08-13

7.  Thyroid cancer: current molecular perspectives.

Authors:  Francesca Giusti; Alberto Falchetti; Francesco Franceschelli; Francesca Marini; Annalisa Tanini; Maria Luisa Brandi
Journal:  J Oncol       Date:  2010-03-29       Impact factor: 4.375

8.  Detection and classification of thyroid follicular lesions based on nuclear structure from histopathology images.

Authors:  Wei Wang; John A Ozolek; Gustavo K Rohde
Journal:  Cytometry A       Date:  2010-05       Impact factor: 4.355

Review 9.  RAS mutations in thyroid cancer.

Authors:  Gina M Howell; Steven P Hodak; Linwah Yip
Journal:  Oncologist       Date:  2013-07-19

10.  Digital gene expression analysis might aid in the diagnosis of thyroid cancer.

Authors:  H Armanious; B Adam; D Meunier; K Formenti; I Izevbaye
Journal:  Curr Oncol       Date:  2020-05-01       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.